Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
New onset of Graves' disease after controlled ovarian stimulation: A case report and brief literature review.
Int J Gynaecol Obstet
October 2024
Medical Department, ASST Mantova, Mantua, Italy.
Article Synopsis
- A 40-year-old woman with no prior thyroid issues developed Graves' disease (GD) after undergoing controlled ovarian stimulation (OS) for infertility, despite normal thyroid function tests before the last cycle.
- Six weeks post-OS, she experienced severe hyperthyroidism with positive anti-thyrotropin receptor antibodies, confirming a GD diagnosis, and started anti-thyroid treatment.
- Thyroid function remained suboptimal after a year of treatment, leading to a recommendation to postpone further OS cycles until her thyroid condition improved, with possible consideration of surgery if she still wanted to become pregnant.
Recurrent laryngeal nerve monitoring by flexible laryngoscopy during thyroid radiofrequency ablation in the awake patient.
Front Endocrinol (Lausanne)
October 2024
Unit of Endocrinology and Metabolism, Laboratory for Endocrine Disruptors, Istituti Clinici Scientifici Maugeri IRCCS, Pavia, Italy.
Article Synopsis
- Radiofrequency ablation (RFA) is a safe treatment for benign thyroid nodules, but it carries a risk of injury to the recurrent laryngeal nerve (RLN), which can affect voice function.
- The study highlights the use of flexible laryngoscopy (FL) to monitor vocal cord (VC) function during RFA, ensuring safety before treating the second nodule in a patient with hyperthyroidism.
- The findings suggest that using FL is an effective way to minimize RLN injury risk during both single and bilateral RFA treatments, even when the patient is awake.
A systematic review of the incidence of thyroid carcinoma in patients undergoing thyroidectomy for thyrotoxicosis.
Clin Otolaryngol
July 2020
ENT Consultant, Surrey & Sussex NHS Trust, Redhill, UK.
Introduction: Hyperthyroidism (HT) has been associated with no insignificant rates of thyroid malignancy. There are no current specific guidelines that suggest routine preoperative imaging for thyroid nodules in patients with Grave's disease. We therefore performed a systematic review assessing rates of thyroid malignancy in patients undergoing surgery for different causes of HT: Grave's disease (GD), toxic adenoma (TA) and toxic multinodular goitre (TMNG).
View Article and Find Full Text PDFGraves' disease complicated by fetal goitrous hypothyroidism treated with intra-amniotic administration of levothyroxine.
BMJ Case Rep
August 2019
Endocrinology, Centro Hospitalar de Vila Nova de Gaia Espinho EPE, Vila Nova de Gaia, Portugal.
Fetal goitrous hypothyroidism is a rare entity and is caused mainly by maternal treatment of Graves' disease (GD). We report a case of a 22-year-old woman referred at 12 weeks of gestation due to hyperthyroidism subsequent to recently diagnosed GD. She started treatment with propylthiouracil and, at 21 weeks of gestation, fetal goitre was detected.
View Article and Find Full Text PDFEpidemiology of hyperthyroidism in Iran: a systematic review and meta-analysis.
J Diabetes Metab Disord
December 2018
1Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Background: Hyperthyroidism is a systemic disorder that causes severe morbidity and is even fatal. Several studies have been performed in Iran to determine the epidemiologic properties of hyperthyroidism; however, they did not use a systematic approach or meta-analysis to evaluate the results. Therefore, this systematic review and meta-analysis aimed to evaluate the epidemiologic data on hyperthyroidism in Iran.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!